Mitochondrial Peroxiredoxin-3 protects against hyperglycemia induced myocardial damage in Diabetic cardiomyopathy
- 1 August 2016
- journal article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 97, 489-500
Abstract
No abstract availableKeywords
Funding Information
- DBT
- University Grants Commission
- UGC
This publication has 41 references indexed in Scilit:
- RETRACTED ARTICLE: Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial functionBMC Medicine, 2012
- Quercetin Induces the Expression of Peroxiredoxins 3 and 5 via the Nrf2/NRF1 Transcription PathwayInvestigative Ophthalmology & Visual Science, 2011
- Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitusNutrition Research and Practice, 2011
- Downregulation of the c‐MYC target gene, peroxiredoxin III, contributes to arsenic trioxide‐induced apoptosis in acute promyelocytic leukemiaInternational Journal of Cancer, 2009
- Diabetic Cardiomyopathy RevisitedCirculation, 2007
- Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signalingFree Radical Biology and Medicine, 2005
- Human mitochondrial peroxiredoxin 5 protects from mitochondrial DNA damages induced by hydrogen peroxideFEBS Letters, 2005
- PeroxiredoxinsBiological Chemistry, 2002
- Diabetic cardiomyopathy: fact or fiction?Heart, 2001
- New type of cardiomyopathy associated with diabetic glomerulosclerosisThe American Journal of Cardiology, 1972